Track the Aptus Pharma stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €4.9bn. The latest transaction was disclosed on 27 May 2026 (Acquisition). Among the most active insiders: Gaurang Thakker. The full history is free.
9
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Fundamental score
Ranked 12,629 of 29,063 companies
55.4
score / 100
Value
35
Quality
76
FCF yld-1.6%
Earn yld0.8%
EV/EBITDA·
ROE30%
Gross mgn54%
Net mgn9.9%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.